BioSpace News Archive

Deals

Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.

Biotech Acquisition Company (NASDAQ: BIOT) (“BAC”), today announced that it has made a submission to the United States Securities and Exchange Commission (“SEC”) of a prospectus supplement containing information supplements and updates to the information contained in the proxy statement/prospectus dated May 9, 2022.

May 24, 2022
·
10 min read
BioMidwest

MMS Holdings Selects THREAD as Partner of Choice to Deliver Decentralized Clinical Trials

MMS Holdings Inc. (MMS) – an award-winning, data-focused contract research organization (CRO) – announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trial platform (DCT) and DCT-enabled services.

May 24, 2022
·
3 min read